Bernstein Liebhard LLP Reports On Upcoming FDA Meeting Seeking Input From Patients On Drug And Medical Device Regulatory Processes
Bernstein Liebhard LLP, a nationwide law firm representing clients with defective medical devices such as pelvic mesh implants and metal hip replacements, is pleased to report on the inaugural U.S. Food and Drug Administration (“FDA”) Patient Network Annual Meeting, to be held on May 18, 2012. The one-day meeting will: (1) review the drug and medical device regulatory processes; (2) discuss where patient input is practical and most valuable; and (3) explore practical approaches to collecting meaningful patient input. The meeting is to be held on the FDA White Oak Campus, in Silver Spring, Maryland. The FDA encourages patients, caregivers and patient advocates to attend, as well as health professionals, academia, industry representatives, and other members of the general public. The inaugural meeting is hosted in conjunction with the launch of the FDA Patient Network, a new resource that seeks to educate patient stakeholders about FDA regulatory processes and programs, and provide a venue for advocacy.
FDA Meeting Will Garner Patient Perspectives On Regulatory Decision-making
The FDA meeting will help facilitate future patient input on its decision making process. “The medical product review process could benefit from a more scientific, systematic, and expansive approach to obtaining input from patients who are experiencing a particular disease condition,” a Federal Register supplementary notice about the FDA Patient Network explained. The FDA plans to jumpstart its efforts to conduct meetings with patients and patient advocacy groups. It will raise a series of questions to facilitate public discussions on the subject, such as how to implement the best methods and venues for discussion. The FDA also intends to discuss factors specific to patient diseases, such as understanding disease conditions, assessment of treatment options, and understanding risks patients are willing to undergo for treatment.
Bernstein Liebhard LLP is encouraged that the FDA is seeking patient input on these important issues, especially in light of the recent DePuy hip recall and FDA warnings concerning pelvic mesh implants. The lawyers at our firm represent hundreds of patients alleging injuries stemming from these medical devices.
Those who have suffered damages from pelvic mesh implants or metal hip replacements may be entitled to compensation for medical expenses, pain and suffering, lost wages and other injuries. Learn more by watching this pelvic mesh or metal hip replacement video, or by visiting our website, www.consumerinjurylawyers.com.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.
Bernstein Liebhard LLP 10 East 40th Street New York, New York 10016 (877) 779-1414
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.